schiff move free advanced
reckitt benckiser pty ltd - acacia catechu,bovine sodium chondroitin sulfate,glucosamine hydrochloride,scutellaria baicalensis -
acacia arabica granule (2dh-30dh) tablet
homeocan inc. - acacia - tablet - 2dh - acacia 2dh - homeopathic products
acacia arabica globules
homeocan inc. - acacia - globules - 2x - acacia 2x - homeopathic products
flavocoxid capsule
n/a; importer: n/a; distributor: n/a - scutellaria baicalensis (baikal skullcap) root extract , acacia catechu (catechu) heartwood extract - capsule - formulation: each 500 mg capsule contains: scutellaria baicalensis (baikal skullcap) root extract................380 mg acacia
eagle curcuvestin complex
integria healthcare australia pty ltd - acacia catechu,curcumin,scutellaria baicalensis -
move free advanced
reckitt benckiser pty ltd - acacia catechu,bovine sodium chondroitin sulfate,glucosamine hydrochloride,scutellaria baicalensis -
nature’s way joint restore 7 day formula
pharmacare laboratories pty ltd - acacia catechu,glucosamine hydrochloride,scutellaria baicalensis -
robina pseudo acacia granule 1dh - 30ch tablet
dolisos laboratoires s.a. - acacia - tablet - 1dh - acacia 1dh - homeopathic products
robina pseudo acacia goutte 4ch-30ch drops
dolisos laboratoires s.a. - acacia - drops - 1ch - acacia 1ch - homeopathic products
center-al - acacia longifolia pollen- acacia longifolia pollen injection, suspension center-al - alnus incana ssp. rugosa polle
alk-abello, inc. - acacia longifolia pollen (unii: 24so2j296o) (acacia longifolia pollen - unii:24so2j296o) - acacia longifolia pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w